ctrl K

Watchlist Price Alert

Sio Gene Therapies Inc. (SIOX)

NASDAQ: SIOX · Real-Time Price · USD

0.48

0.09 (23.14%)

At close: Feb 07, 2024, 8:58 PM

Sio Gene Therapies Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-72.27M	-34.3M	-67.81M	-127.02M	-213.32M	-180.5M	-133.16M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-71.63M	-32.64M	-72.19M	-128.93M	-220.65M	-182.01M	-133.16M
Net Income	-71.89M	-32.42M	-72.63M	-129.06M	-221.57M	-180.95M	-133.15M
Selling & General & Admin	18.16M	17.29M	22.06M	39.47M	71.91M	45.72M	56.52M
Research & Development	53.4M	24.9M	47.11M	87.55M	141.41M	134.78M	76.64M
Other Expenses	-39K	10.36M	1.36M	5.62M	211K	-369K	133.16M
Operating Expenses	71.56M	42.2M	69.17M	127.02M	213.32M	180.5M	133.16M
Interest Expense	27K	799K	4.38M	7.53M	7.54M	1.14M	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	71.56M	42.2M	69.17M	127.02M	213.32M	180.5M	133.16M
Income Tax Expense	259K	-212K	438K	133K	921K	-1.06M	-17K
Shares Outstanding (Basic)	73.21M	52.18M	24.81M	16.1M	13.42M	12.39M	11.81M
Shares Outstanding (Diluted)	73.21M	52.18M	24.81M	16.1M	13.42M	12.39M	11.81M
EPS (Basic)	-0.98	-0.62	-2.93	-8.02	-16.51	-14.6	-11.28
EPS (Diluted)	-0.98	-0.62	-2.93	-8.02	-16.51	-14.6	-11.28
EBITDA	-70.94M	-29.37M	n/a	-121.4M	-210.02M	-179.48M	n/a
EBIT	-71.6M	-31.84M	n/a	-121.4M	-213.11M	-179.72M	n/a
Depreciation & Amortization	666K	2.47M	3.09M	2.45M	3.08M	249K	14K